Last updated on August 2018

Evaluation of the DIABEO System in Poorly Controlled DM1 or DM2 Patients Treated With a Basal-bolus Insulin Regimen

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: NIDDM | Diabetes Mellitus
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Type 1 or type 2 diabetic patients
  • Performing auto-glycaemic control (at least 2 glycemias a day)
  • Treated with insulin by a basal-bolus regimen for at least 1 year and using the same method of administration for at least 3 months (insulin pen or pump)
  • Who have an Apple or Androde Smartphone compatible, or intend to acquire one before their participation in the study
  • Whose HbA1c dating of less 1 month and more than 3 months is 8%
  • Who are able to understand and follow the study protocol
  • Who have given their signed consent to take part in the study
  • Subject affiliated to the French National Health Insurance funds or benefiting from such insurance

Exclusion Criteria:

  • Age < 18 years old
  • Patients who have used the DIABEO system within 6 months before inclusion
  • Participation in a clinical study within 6 months, except for the Meos (or tldiab 3) study after a participation period of 6 months
  • Patients who are pregnant or who wish to become pregnant during the study.
  • Patients treated with human insulin A patient pre-screening register will be set up in each centre to establish the reasons for DM1/DM2 patients treated with a basal-bolus insulin regimen who are not taking part in the study.

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.